Linked Data API

Show Search Form

Search Results

1024789
registered interest false more like this
date less than 2018-12-13more like thismore than 2018-12-13
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Ovarian Cancer: Staffordshire more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps he is taking to (a) increase early diagnosis rates for ovarian cancer and (b) increase access to treatment for ovarian cancer in specialist centres in Staffordshire. more like this
tabling member constituency Newcastle-under-Lyme more like this
tabling member printed
Paul Farrelly remove filter
uin 202081 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-12-18more like thismore than 2018-12-18
answer text <p>Public Health England (PHE) has run a number of ‘Be Clear on Cancer’ campaigns to help improve early detection of cancer including ovarian cancer. In 2014 PHE ran a pilot regional ovarian cancer campaign in the North West of England. In 2017, PHE ran a pilot campaign in the East and West Midlands which focussed on a range of abdominal symptoms, such as diarrhoea, bloating and discomfort that can be indicative of a number of cancers, including ovarian cancer. NHS England has invested over £200 million between 2017 and 2019, supporting Cancer Alliances to accelerate diagnosis and enhance quality of life.</p><p> </p><p>Staffordshire clinical commissioning groups commission diagnostic services for ovarian cancer fully in line with National Institute for Health and Care Excellence guidelines across the whole sustainability and transformation partnership.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2018-12-18T17:04:54.847Zmore like thismore than 2018-12-18T17:04:54.847Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
1436
label Biography information for Paul Farrelly more like this
1022956
registered interest false more like this
date less than 2018-12-10more like thismore than 2018-12-10
answering body
Department for Education more like this
answering dept id 60 more like this
answering dept short name Education more like this
answering dept sort name Education more like this
hansard heading Children: Social Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Education, what recent assessment he has made of the correlation between deprivation and demand for children’s services. more like this
tabling member constituency Newcastle-under-Lyme more like this
tabling member printed
Paul Farrelly remove filter
uin 200581 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-12-13more like thismore than 2018-12-13
answer text <p>Demand for children’s services is associated with a number of factors, including deprivation. The most deprived local authorities (LAs) have more looked after children (per 10,000 17 year olds), and these rates have grown faster than the least deprived LAs.</p><p>In preparation for the Spending Review, to help ensure decisions are based on the best available evidence, the government is working with the sector to develop a sharper and more granular picture of demand for children’s services.</p><p>We are also working with Ministry of Housing, Communities and Local Government as part of the Government’s Fair Funding Review of relative needs and resources, where new, up-to-date formulas are being developed to ensure funding distribution to councils is based on the best available evidence.</p><p>We welcome the contributions from the sector in this area, including Newton Europe’s Making Sense (2018) report and the Association of Directors of Children’s Services' continuing research reports, Safeguarding Pressures (2018).</p>
answering member constituency Stratford-on-Avon more like this
answering member printed Nadhim Zahawi more like this
question first answered
less than 2018-12-13T14:41:48.833Zmore like thismore than 2018-12-13T14:41:48.833Z
answering member
4113
label Biography information for Nadhim Zahawi more like this
tabling member
1436
label Biography information for Paul Farrelly more like this
1020404
registered interest false more like this
date less than 2018-12-05more like thismore than 2018-12-05
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Medicines and Healthcare products Regulatory Agency more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 03 December 2018 to Question 196736 on Medicines and Healthcare Products Regulatory Agency (MHRA), and with reference to the transition period set out in the Agreement on the Withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union, if the MHRA will be recognised as an EU competent authority under the EU (a) Medical Devices Directive, (b) in-vitro diagnostic medical devices, and (c) Medical Devices Regulation during the period covered by the Agreement. more like this
tabling member constituency Newcastle-under-Lyme more like this
tabling member printed
Paul Farrelly remove filter
uin 199325 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-12-10more like thismore than 2018-12-10
answer text <p>The agreement of an implementation period will mean that the Medicines and Healthcare products Regulatory Agency (MHRA) will continue to be recognised as a European Union competent authority designated under the EU Directives for medical devices, in vitro diagnostic medical devices and active implantable medical devices, during this period.</p><p> </p><p>This is also the case for the new EU Regulations for medical devices and in vitro diagnostic medical devices, which both entered into force in May 2017.</p><p> </p><p>It is possible for a single organisation to have individual notified bodies designated in more than one Member State. The authority within each Member State is responsible for notified bodies based in its own country.</p><p> </p><p>The MHRA is responsible for the designation and monitoring of notified bodies in the United Kingdom, which the response to Question 196736 refers to.</p> more like this
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
grouped question UIN 199327 more like this
question first answered
less than 2018-12-10T14:12:25.46Zmore like thismore than 2018-12-10T14:12:25.46Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
1436
label Biography information for Paul Farrelly more like this
1020405
registered interest false more like this
date less than 2018-12-05more like thismore than 2018-12-05
answering body
Department for Exiting the European Union more like this
answering dept id 203 more like this
answering dept short name Exiting the European Union more like this
answering dept sort name Exiting the European Union more like this
hansard heading Medicines and Healthcare products Regulatory Agency more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Exiting the European Union, pursuant to the Answer of 03 December 2018 to Question 196736 on Medicines and Healthcare Products Regulatory Agency (MHRA) and with reference to the transition period set out in the Agreement on the Withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union, if the MHRA will be recognised as an EU competent authority under EU Regulations (a) Medical Devices Directive, (b) in-vitro diagnostic medical devices, and (c) Medical Devices Regulation during that period. more like this
tabling member constituency Newcastle-under-Lyme more like this
tabling member printed
Paul Farrelly remove filter
uin 199326 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-12-10more like thismore than 2018-12-10
answer text <p>The agreement of an implementation period will mean that the Medicines and Healthcare products Regulatory Agency (MHRA) will continue to be recognised as an EU competent authority designated under the EU Directives for medical devices, in vitro diagnostic medical devices and active implantable medical devices, during this period.</p><p>This is also the case for the new EU Regulations for medical devices and in vitro diagnostic medical devices, which both entered into force in May 2017.</p><p><strong></strong><br><br></p><p> </p> more like this
answering member constituency Daventry more like this
answering member printed Chris Heaton-Harris more like this
question first answered
less than 2018-12-10T15:48:34.12Zmore like thismore than 2018-12-10T15:48:34.12Z
answering member
3977
label Biography information for Chris Heaton-Harris more like this
tabling member
1436
label Biography information for Paul Farrelly more like this
1020408
registered interest false more like this
date less than 2018-12-05more like thismore than 2018-12-05
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Medical Equipment: UK Notified Bodies more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 03 December 2018 to Question 196736 on Medicines and Healthcare Products Regulatory Agency (MHRA), whether the Department's response refers to (a) UK notified bodies licensed by the MHRA and (b) UK notified bodies that have also secured notified body status in other EU states. more like this
tabling member constituency Newcastle-under-Lyme more like this
tabling member printed
Paul Farrelly remove filter
uin 199327 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-12-10more like thismore than 2018-12-10
answer text <p>The agreement of an implementation period will mean that the Medicines and Healthcare products Regulatory Agency (MHRA) will continue to be recognised as a European Union competent authority designated under the EU Directives for medical devices, in vitro diagnostic medical devices and active implantable medical devices, during this period.</p><p> </p><p>This is also the case for the new EU Regulations for medical devices and in vitro diagnostic medical devices, which both entered into force in May 2017.</p><p> </p><p>It is possible for a single organisation to have individual notified bodies designated in more than one Member State. The authority within each Member State is responsible for notified bodies based in its own country.</p><p> </p><p>The MHRA is responsible for the designation and monitoring of notified bodies in the United Kingdom, which the response to Question 196736 refers to.</p> more like this
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
grouped question UIN 199325 more like this
question first answered
less than 2018-12-10T14:12:25.523Zmore like thismore than 2018-12-10T14:12:25.523Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
1436
label Biography information for Paul Farrelly more like this
1016320
registered interest false more like this
date less than 2018-11-28more like thismore than 2018-11-28
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Medicines and Healthcare products Regulatory Agency more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, with reference to the transition period set out in the agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union, whether the Medicines and Healthcare Products Regulatory Agency will retain its status as a competent authority; and whether existing CE marks assigned under that agency will be valid from 29 March 2019 until the end of that transition period. more like this
tabling member constituency Newcastle-under-Lyme more like this
tabling member printed
Paul Farrelly remove filter
uin 196736 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-12-03more like thismore than 2018-12-03
answer text <p>The agreement of an implementation period will ensure that access to medicines and medical devices continues, and patient safety is maintained, in both the United Kingdom and European Union markets.</p><p> </p><p>The Medicines and Healthcare products Regulatory Agency (MHRA) will continue to be the UK competent authority during this period.</p><p> </p><p>For medical devices, CE marks are assigned by notified bodies (rather than competent authorities such as the MHRA), and during the implementation period UK notified bodies will continue to conduct third-party conformity assessment in the UK, and the results of these tests will continue to be used and recognised for both the UK and EU markets.</p> more like this
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
question first answered
less than 2018-12-03T18:29:34.66Zmore like thismore than 2018-12-03T18:29:34.66Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
1436
label Biography information for Paul Farrelly more like this
1012292
registered interest false more like this
date less than 2018-11-22more like thismore than 2018-11-22
answering body
Department for Business, Energy and Industrial Strategy more like this
answering dept id 201 more like this
answering dept short name Business, Energy and Industrial Strategy more like this
answering dept sort name Business, Energy and Industrial Strategy more like this
hansard heading Copyright: EU Action more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Business, Energy and Industrial Strategy, with reference to the Trilogue process in relation to the EU Directive on Copyright in the Digital Single Market, whether the Government plans to support the inclusion of provisions to ensure that creators receive fair remuneration for the use of their works. more like this
tabling member constituency Newcastle-under-Lyme more like this
tabling member printed
Paul Farrelly remove filter
uin 194603 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-11-27more like thismore than 2018-11-27
answer text <p>The Government supports the principle that creators should be fairly rewarded for their work whilst ensuring that we continue to encourage investment in new content and innovative services. We are engaging with our European partners to achieve these aims during Trilogue negotiations on this Directive.</p> more like this
answering member constituency East Surrey more like this
answering member printed Mr Sam Gyimah more like this
question first answered
less than 2018-11-27T14:50:26.217Zmore like thismore than 2018-11-27T14:50:26.217Z
answering member
3980
label Biography information for Mr Sam Gyimah more like this
tabling member
1436
label Biography information for Paul Farrelly more like this
1012293
registered interest false more like this
date less than 2018-11-22more like thismore than 2018-11-22
answering body
Department for Business, Energy and Industrial Strategy more like this
answering dept id 201 more like this
answering dept short name Business, Energy and Industrial Strategy more like this
answering dept sort name Business, Energy and Industrial Strategy more like this
hansard heading Copyright: EU Countries more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of the potential effect of the UK leaving the EU on the reciprocal relationships the UK has with the EU that enable collective management organisations to collect royalties from EU countries and distribute to creators in the UK. more like this
tabling member constituency Newcastle-under-Lyme more like this
tabling member printed
Paul Farrelly remove filter
uin 194604 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-11-27more like thismore than 2018-11-27
answer text <p>The Government has considered this issue in the context of its Brexit analysis. It has concluded that the reciprocal arrangements between UK Collective Management Organisations (CMOs) and EU CMOs to collect royalties from EU countries and distribute to creators in the UK are private commercial agreements which are expected to continue after the UK has exited the European Union.</p> more like this
answering member constituency East Surrey more like this
answering member printed Mr Sam Gyimah more like this
question first answered
less than 2018-11-27T15:43:32.79Zmore like thismore than 2018-11-27T15:43:32.79Z
answering member
3980
label Biography information for Mr Sam Gyimah more like this
tabling member
1436
label Biography information for Paul Farrelly more like this
1012294
registered interest false more like this
date less than 2018-11-22more like thismore than 2018-11-22
answering body
Department for Digital, Culture, Media and Sport more like this
answering dept id 10 more like this
answering dept short name Digital, Culture, Media and Sport more like this
answering dept sort name Digital, Culture, Media and Sport more like this
hansard heading Arts: EU Grants and Loans more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Digital, Culture, Media and Sport, whether the Government plans to remain part of Creative Europe after the current funding period concludes in 2020. more like this
tabling member constituency Newcastle-under-Lyme more like this
tabling member printed
Paul Farrelly remove filter
uin 194605 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-11-27more like thismore than 2018-11-27
answer text The UK will always be a European country that advocates for cultural diversity as part of its global identity and is committed to continuing its contribution to and support of European culture. The Government has been clear that will be explore participation in any successor programme to Creative Europe. Where EU funding programmes are to the UK and EU's joint advantage, we want to discuss continued participation as part of the negotiations. Ultimately, the decision on which programmes are in the UK’s interests will be decided as part of the future partnership negotiations, which are ongoing. more like this
answering member constituency Stourbridge more like this
answering member printed Margot James more like this
question first answered
less than 2018-11-27T19:18:35.98Zmore like thismore than 2018-11-27T19:18:35.98Z
answering member
4115
label Biography information for Margot James more like this
tabling member
1436
label Biography information for Paul Farrelly more like this
1010153
registered interest false more like this
date less than 2018-11-19more like thismore than 2018-11-19
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Eating Disorders more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 October 2018 to Question 177617 on Eating disorders, if he will list the 70 new or extended community services providing specialist community-based care for eating disorders that are open or in development by the local authority in which they are based. more like this
tabling member constituency Newcastle-under-Lyme more like this
tabling member printed
Paul Farrelly remove filter
uin 192754 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-11-22more like thismore than 2018-11-22
answer text <p>This information is not available by local authority.</p> more like this
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
question first answered
less than 2018-11-22T17:42:15.717Zmore like thismore than 2018-11-22T17:42:15.717Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
1436
label Biography information for Paul Farrelly more like this